Skip to main content
. 2019 May 29;20(11):2646. doi: 10.3390/ijms20112646

Figure 3.

Figure 3

Effects of different concentrations of ZF1 on metabolic activity in hASCs. The percentage of resazurin reduction (as an indicator of cell proliferation) in hASCs treated with ZF1 (0.01, 10, and 20 μg/mL) or a solvent (SOLV) or untreated (CTR). An analysis was conducted at 4, 24, 48, and 72 h from the beginning of the treatment and an experiment was performed in technical quadruplicate. Statistical significance was evaluated using ANOVA followed by the Tukey HSD test. Data are expressed as mean ± standard deviation (SD), n = 4.